Lineage Cell Therapeutics (LCTX) Stock Chart & Stock Price History $0.42 -0.02 (-4.55%) Closing price 04/3/2025 04:10 PM EasternExtended Trading$0.42 +0.00 (+0.17%) As of 04/3/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Lineage Cell Therapeutics Stock Price Performance 5 Day Performance-15.17%1 Month Performance-18.19%3 Month Performance-29.28%6 Month Performance-54.64%Year-To-Date Performance-16.96%1 Year Performance-71.80% Receive LCTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address LCTX Stock Chart for Friday, April, 4, 2025 LCTX Chart by TradingViewRemove Ads Lineage Cell Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/03/2025$0.44$0.42-4.55%$0.42$0.411.14 million shs$91.98 million04/02/2025$0.41$0.44+6.37%$0.45$0.41995,846 shs$96.37 million04/01/2025$0.45$0.41-8.99%$0.47$0.402.54 million shs$90.59 million03/31/2025$0.49$0.45-8.19%$0.49$0.451.84 million shs$99.54 million03/28/2025$0.50$0.49-0.95%$0.50$0.481.34 million shs$108.43 million03/27/2025$0.50$0.50-0.70%$0.51$0.471.52 million shs$109.46 million03/26/2025$0.52$0.50-2.89%$0.52$0.501.32 million shs$110.23 million03/25/2025$0.54$0.52-3.97%$0.54$0.52732,818 shs$113.52 million03/24/2025$0.51$0.54+5.88%$0.55$0.501.62 million shs$118.21 million03/21/2025$0.50$0.51+1.30%$0.54$0.496.41 million shs$111.64 million Get the Latest News and Ratings for LCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/20/2025$0.49$0.50+1.13%$0.53$0.492.00 million shs$110.21 million03/19/2025$0.48$0.49+2.64%$0.53$0.481.23 million shs$108.98 million03/18/2025$0.50$0.48-3.66%$0.51$0.482.41 million shs$106.18 million03/17/2025$0.52$0.50-3.85%$0.53$0.502.86 million shs$110.21 million03/14/2025$0.52$0.52$0.55$0.52875,391 shs$114.62 million03/13/2025$0.52$0.52-0.04%$0.56$0.522.14 million shs$114.62 million03/12/2025$0.53$0.52-2.38%$0.55$0.521.68 million shs$114.66 million03/11/2025$0.53$0.53+0.36%$0.55$0.501.72 million shs$117.46 million03/10/2025N/A$0.53$0.58$0.511.87 million shs$117.04 million03/03/2025N/A$0.51$0.59$0.511.33 million shs$0.00 Related Companies ORIC Pharmaceuticals Stock Price Chart ABIVAX Société Anonyme Stock Price Chart SIGA Technologies Stock Price Chart Tourmaline Bio Stock Price Chart Erasca Stock Price Chart Altimmune Stock Price Chart Oruka Therapeutics Stock Price Chart Revance Therapeutics Stock Price Chart Kamada Stock Price Chart Sana Biotechnology Stock Price Chart Receive LCTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:LCTX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LCTX Stock Free LCTX Stock Alerts